Imprimis Pharma Launches and Customizable Formulation of Pyrimethamine and Leucovorin Available for Physicians to Prescribe for their Patients as an Alternative to Daraprim® Imprimis forms Imprimis Cares to help combat the high prices of sole source legacy generic drugs

Imprimis Pharmaceuticals to Make Compounded and Customizable ...

PR Newswire (press release)-1 hour ago

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development ...

Imprimis Pharma (IMMY) Launches Customizable Compounded ...
StreetInsider.com-1 hour ago

Explore in depth (9 more articles)